Dr. Kassam, thank you for the opportunity to speak about this exciting new standard of care!
David Dawe
@drdaviddawe
Medical oncologist treating thoracic cancer and researching treatment disparities, cancer, aging, and frailty. he/him, views my own.
334 Following 174 Followers 281 Posts
Latest posts 5
Starting Lung Cancer Awareness month with the Best of Lung Cancer 2024!
Great agenda with lots to learn!
oncologyeducation.com/events/best-of…
Great agenda with lots to learn!
oncologyeducation.com/events/best-of…
www.oncologyeducation.com Best of Lung Cancer Conference 2024 - OncologyEducation Chaired by Dr. Paul Wheatley-Price and Dr. Penelope Bradbury, the Best of Lung Cancer Conference 2024 offers Canadian oncology professionals a unique opportunity to stay current on the most impactful... New paper investigating the intersection of comorbidity, polypharmacy and age in adults with cancer.
Free access until March 3, 2024
authors.elsevier.com/a/1iQGh6hK%7E0…
@CCMB_Research @UM_RadyFHS @CIHR_IRSC
Free access until March 3, 2024
authors.elsevier.com/a/1iQGh6hK%7E0…
@CCMB_Research @UM_RadyFHS @CIHR_IRSC
IND.227 phase III results now available on The Lancet online!
Represents an additional standard of care to existing options.
Thank you to the participating patients and their families!
@CDNCancerTrials @CCMB_Research @CancerCareMB @UM_RadyFHS
Link:
authors.elsevier.com/c/1i1UOV-4XL4B8
Represents an additional standard of care to existing options.
Thank you to the participating patients and their families!
@CDNCancerTrials @CCMB_Research @CancerCareMB @UM_RadyFHS
Link:
authors.elsevier.com/c/1i1UOV-4XL4B8
Access to our paper (IND.227 phase II component) reporting on chemoimmunotherapy in patients with mesothelioma available through the link below until May 12th.
@CDNCancerTrials @CCMB_Research @CancerCareMB
authors.elsevier.com/c/1goEI5Xq2QUv…
@CDNCancerTrials @CCMB_Research @CancerCareMB
authors.elsevier.com/c/1goEI5Xq2QUv…